PTC THERAPEUTICS
PTC Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of orally administered and small-molecule drugs. It offers Ataluren, an orally administered small-molecule investigational new drug for the treatment of cystic fibrosis and duchenne muscular dystrophy caused by nonsense mutations. The company also provides PTC299, an anti-angiogenesis drug for the treatment of metastatic breast cancer, multiple tumors, and neurofibromatosis. Its products are used for the treatment of genetic disorders, oncology, and infectious diseases. PTC Therapeutics, Inc. was founded in 1998 and is based in South Plainfield, New Jersey.
PTC THERAPEUTICS
Industry:
Biotechnology Health Care Therapeutics
Founded:
1998-01-01
Address:
South Plainfield, New Jersey, United States
Country:
United States
Website Url:
http://www.ptcbio.com
Total Employee:
101+
Status:
Active
Contact:
9082227231
Email Addresses:
[email protected]
Total Funding:
568.05 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon WordPress Wordpress Plugins Nginx Sitelinks Search Box Microsoft Exchange Online
Similar Organizations
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Keros Therapeutics
Keros is a clinical-stage biopharmaceutical company focusing on the discovery, development, and commercialization of novel treatments.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2020-05-06 | Censa Pharmaceuticals | Censa Pharmaceuticals acquired by PTC Therapeutics | N/A |
| 2019-10-25 | BioElectron Technology Corporation | BioElectron Technology Corporation acquired by PTC Therapeutics | 210 M USD |
| 2018-07-19 | Agilis Biotherapeutics | Agilis Biotherapeutics acquired by PTC Therapeutics | 200 M USD |
Investors List
Jennison Associates
Jennison Associates investment in Private Equity Round - PTC Therapeutics
Vulcan Capital
Vulcan Capital investment in Private Equity Round - PTC Therapeutics
Adage Capital Management
Adage Capital Management investment in Private Equity Round - PTC Therapeutics
Delphi Ventures
Delphi Ventures investment in Private Equity Round - PTC Therapeutics
Brookside Capital
Brookside Capital investment in Private Equity Round - PTC Therapeutics
Novo Holdings
Novo Holdings investment in Private Equity Round - PTC Therapeutics
Longwood Fund
Longwood Fund investment in Private Equity Round - PTC Therapeutics
Credit Suisse
Credit Suisse investment in Private Equity Round - PTC Therapeutics
Novo Holdings
Novo Holdings investment in Private Equity Round - PTC Therapeutics
Credit Suisse
Credit Suisse investment in Private Equity Round - PTC Therapeutics
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2020-01-13 | ClearPoint Neuro | PTC Therapeutics investment in Post-IPO Equity - ClearPoint Neuro | 17.5 M USD |
Newest Events participated
Participated in OrphanDrug Congress USA 2017
on 2017-04-19 as sponsor
Participated in The Conference of Things Manufacturing
on 2015-11-26 as sponsor
Key Employee Changes
| Date | New article |
|---|---|
| 2020-04-17 | PTC Therapeutics elevates biotech buyout CEO to chief development officer |
Official Site Inspections
http://www.ptcbio.com Semrush global rank: 1.35 M Semrush visits lastest month: 21.46 K
- Host name: 23.185.0.4
- IP address: 23.185.0.4
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "PTC Therapeutics"
About PTC Therapeutics - Treatments for Rare Diseases
PTC is committed to providing access to best-in-class treatments for patients with little to no treatment options. This mission underpins our focus on the discovery, development, and global commercialization of clinically differentiated …See details»
PTC Therapeutics - Meet our Leadership Team
The executive leadership team at PTC Therapeutics is a profoundly inspiring group of innovators working toward a brighter future for rare disease treatments.See details»
PTC Therapeutics - ptcbio-en.se
During 2016, Mr. Southwell served on the board of directors of inVentiv Health, Inc., a contract research organization prior to its recapitalization in late 2016. From 2007 to 2016, Mr. …See details»
PTC Therapeutics, Inc. | LinkedIn
PTC Therapeutics, Inc. | 76,986 followers on LinkedIn. We're committed to a single purpose: Extending life’s moments for patients with rare diseases and their loved ones. | PTC is a …See details»
Investors | PTC Therapeutics, Inc.
Investors | PTC Therapeutics, Inc.See details»
PTC Therapeutics - Wikipedia
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by …See details»
PTC Therapeutics - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number 9082227231 PTC Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization …See details»
PTC Therapeutics Enters into a Global License and Collaboration ...
Dec 2, 2024 PTC believes this allows it to maximize value for all its stakeholders. To learn more about PTC, please visit us at www.ptcbio.com and follow us on Facebook, Instagram, LinkedIn …See details»
PTC Therapeutics
Founded in 1998, PTC Therapeutics is a global commercial, diversified biopharmaceutical company with a footprint in more than 50 countries across the planet.See details»
PTC Therapeutics - Responsibilities and Global Initiatives
We work hard to provide resources and support to patients and their families through compassionate collaboration, throughout the drug development process. We strive to ensure …See details»
PTC Therapeutics Provides Corporate Update and Reports Fourth …
Feb 27, 2025 [email protected] . Media: Jeanine Clemente +1 (908) 912-9406 [email protected] . Forward-Looking Statements: This press release contains forward …See details»
Careers - Our People - PTC Therapeutics (United States) - ptcbio.com
The Organization for Hispanic/Latinx Alliance (OHLA) unites the Hispanic/Latino community through a collaborative network and promotes the heritage of Hispanic or Latino employees by …See details»
Welcome to PTC Therapeutics Clinical Trials
By participating in a clinical trial, you are taking an active role in the development and approval of new medicines and treatments. People who volunteer in clinical trials provide the medical …See details»
Our Products - PTC Therapeutics (United States)
Please note, our products are approved in individual countries for specific uses and the information provided is governed by local regulations. The name, availability and indication of …See details»
MEDhub Home - Latest scientific data and expert insights
Aug 1, 2024 This website is organized and funded by PTC Therapeutics for healthcare professionals only. For medical inquiries get in touch at [email protected] This website …See details»
Release Details - PTC Therapeutics, Inc.
Sep 28, 2023 PTC believes this allows it to maximize value for all its stakeholders. To learn more about PTC, please visit us at www.ptcbio.com and follow us on Facebook, Instagram, …See details»
Careers - Our Culture - PTC Therapeutics (United States)
For us, changing the course of rare diseases isn’t a job, it is our purpose. Our deep passion for patients drives us to think differently about solutions and to work collaboratively as One PTC. …See details»
PTC Therapeutics Provides Corporate Update and Highlights …
Jan 13, 2020 SOUTH PLAINFIELD, N.J., Jan. 13, 2020 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today is providing a corporate update that will be presented at the 38 th …See details»
PTC Therapeutics Provides Corporate Update and Reports First …
May 6, 2025 [email protected]. Media: Jeanine Clemente +1 (908) 912-9406 [email protected]. Forward-Looking Statements: This press release contains forward …See details»
PTC518 PIVOT-HD Study Achieves Primary Endpoint | PTC …
May 5, 2025 To learn more about PTC, please visit www.ptcbio.com and follow on Facebook, X, and LinkedIn. For More Information: Investors: Ellen Cavaleri +1 (615) 618-6228 …See details»